栏目导航

联系我们

全国统一服务热线:400-6872-158
 
杨工:15611601151   (北京、天津、河北、内蒙古、陕西、青海)
 
王工:15652527126  (福建、浙江、广东、江苏、海南、甘肃)
 
蔡工:15652527296  (四川、重庆、河南、上海、江西、山西)
 
张工:15652527216   (山东、安徽、湖北、湖南、广西、贵州)
 
刘工:15652527236   (辽宁、吉林、黑龙江、云南、宁夏、新疆)
 
 
技术支持:010-82176541
公司传真:010-82176542
通讯地址:北京市海淀区上地十街辉煌国际东6号楼3层361室

当前位置:  > 新闻中心 > 新闻动态

In the November edition of Clean Air and Containment Review, Hasim Solmaz, General Manager of Lighthouse EMEA published a very informative overview regarding the creation, implementation and maintaini

点击次数:更新时间:2019-07-18 10:07:42【打印】【关闭】

Clean areas used for aseptic manufacturing of sterile medicinal products are subject to standards and guidelines to ensure quality of production and to minimize risks of particulate and microbiological contamination. In recent years, a proper monitoring plan with a risk-based approach has become a part of many standards and regulations such as ISO 14644-2:2015 and ICH Harmonized Guideline ICHQ9 Quality Risk Management. However it is also obvious that there is a lack of good application practices for proper monitoring plans that are based on risk assessment. This study provides information with an example of how to prepare a risk based monitoring plan incorporating risk assessment tools, current standards, regulations and guidelines.

返回首页 | 产品中心| 应用领域| 新闻中心| 关于我们| 联系我们| 实时询价系统
Copyright 2008│北京中邦兴业科技有限公司│京ICP备11031648号-1│
地址:北京市海淀区上地十街辉煌国际东6号楼3层361室│
销售电话:010-82176540│传真:010-82176542│客户投诉:010-82176541
powerd by BEESCMS © 2010-2015 www.beescms.com